Protocol for chemogenetic activation of basal ganglia D1-MSNs and behavioral assessments in a primate Parkinson’s disease model

A circuit-based gene therapy strategy for Parkinson's disease (PD) has been shown to significantly reverse core symptoms in both murine and primate PD models. Here, we present a comprehensive workflow to specifically manipulate dopamine receptor D<sub>1</sub>-expressing medium spiny neurons by retrograde adeno-associated virus (AAV) transduction and chemogenetic activation using a designer toolkit. We describe steps for AAV injections and PD primate model induction. We then detail behavioral measurements to assess the therapeutic efficacy of the therapy for motor symptoms.

Authors

Institutions

Publication Details

Journal
STAR Protocols
Published
2024-12-01
DOI
https://doi.org/10.1016/j.xpro.2024.103470
Citations
2
Primary Topic
Neurological disorders and treatments
Type
article
Field-Weighted Citation Impact
0.74

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Protocol for chemogenetic activation of basal ganglia D1-MSNs and behavioral assessments in a primate Parkinson’s disease model

Jianbang Lin, Yuyuan Zhu, Taian Liu, Zhonghua Lu et al.
2 citations
STAR Protocols
Neurological disorders and treatments
0.74
article

Protocol for chemogenetic activation of basal ganglia D1-MSNs and behavioral assessments in a primate Parkinson’s disease model

Jianbang Lin, Yuyuan Zhu, Taian Liu, Zhonghua Lu, Ming Guo, Zexuan Hong, Yuantao Li, Ting Yan, Siyang Chen, Shijing Feng, Mengqi Li, Ronghui Li, Jianqing Zhang, Yefei Chen, Yi Yang
article en
2 citations

Abstract

A circuit-based gene therapy strategy for Parkinson's disease (PD) has been shown to significantly reverse core symptoms in both murine and primate PD models. Here, we present a comprehensive workflow to specifically manipulate dopamine receptor D<sub>1</sub>-expressing medium spiny neurons by retrograde adeno-associated virus (AAV) transduction and chemogenetic activation using a designer toolkit. We describe steps for AAV injections and PD primate model induction. We then detail behavioral measurements to assess the therapeutic efficacy of the therapy for motor symptoms.

STAR ProtocolsVol. 5(4)
Chinese Academy of Sciences (CN), Shenzhen Maternity and Child Healthcare Hospital (CN), Shenzhen Institutes of Advanced Technology (CN)
National Natural Science Foundation of China, Chinese Academy of Sciences, China Postdoctoral Science Foundation, Science, Technology and Innovation Commission of Shenzhen Municipality
Zero hunger
Openalex Percentile: Top 25%
Neurological disorders and treatments
0.74
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.